Is Rohto Pharmaceutical stock a buy?
What Is The Conclusion?
Right now our advanced algorithms say:
Do the analyst corps agree?
Interesting Questions and Easy Answers!
Yes, Rohto Pharmaceutical pays dividends. Last time was Sunday 1st of December 2024 where the investors holding the stock on Friday 27th of September 2024 were paid JPY16 per share. Over the last 48 times between 2001 and 2024, Rohto Pharmaceutical has paid JPY153.25 with an average of JPY3.19 per share.
Sorry, we do not have any analyst data for this ticker
We cannot find data for Rohto Pharmaceutical 10 years ago, but if you had invested on Monday 9th of September 2019 when the price was JPY1 340.00, you would have made a profit of JPY2 290.00 per share or 170.90%
Yes, the average daily trading liquidity for Rohto Pharmaceutical is JPY775 512 thousand. You should therefore be able to get in and out of your positions relatively fast.
Rohto Pharmaceutical has no real debt, which is good in periods of high inflation. With a high cash flow to debt ratio of 1.11, the company's ability to pay off the debt is good. Rohto Pharmaceutical has a good net profit margin of 11.74% and should have high tolerances against inflation.
We have calculated the inflation risk for Rohto Pharmaceutical to be low [0.1 of 1]
US inflation for July 2024 was 0.15%. Over the last 12 months, the US inflation is 2.92%. The 10-year treasury yield that indicates the future interest level is currently 3.72 and is down -0.95 over the last 30 days.